ETFChannel.com
Invesco Dynamic Pharmaceuticals ETF

Fund Name:
Invesco Dynamic Pharmaceuticals ETF
Issuer:
Invesco
Total Net Assets:
$314,268,800
Inception:
06/23/2005
Related Index:
DZRTR
ETF Category: 
Health
Expense Ratio: 
0.56% 
Net Asset Value: 
$74.12  
Recent NAV Premium: 
0.00% 
NAV Symbol: 
PJP.NV  
Number of Holdings: 
25  
Annualized Yield: 
0.91%  
Annualized Distribution: 
0.675  
PJP Dividend History » 
Stock Weight Amount
Eli Lilly & Co. 5.94% $18,677,499
Abbvie 5.81% $18,245,806
Gilead Sciences 5.80% $18,222,092
Johnson & Johnson 5.66% $17,799,977
Merck & Co. 5.58% $17,547,557
List of all 25 stocks held by PJP »
Quotes delayed 20 minutes

Email EnvelopeFree PJP Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts

Buy (3.24 out of 4)
58th percentile
(ranked higher than approx. 58% of all etfs covered)
Based on data provided by Zacks Investment Research via Quandl.com
Shares Short 24,306
Chg. from Last Month +1,415
Shares Outstanding 4,240,000
% of Shares Short 0.57%
Days to Cover 3.0
Based on third party short interest data.

PJP | Invesco Dynamic Pharmaceuticals ETF | ETF Channel | www.ETFChannel.com

Copyright © 2010 - 2022, All Rights Reserved Nothing in ETF Channel is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and ETF videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact ETF Channel; Meet Our Editorial Staff.